Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Shanghai Kehua Bio-Engineering Co., Ltd., commonly referred to as Kehua Bio, is a leading player in the biotechnology industry, headquartered in Shanghai, China. Established in 1995, the company has made significant strides in the development and production of high-quality diagnostic reagents and medical devices, catering to both domestic and international markets.
Kehua Bio's core offerings include a diverse range of in vitro diagnostic products, particularly in the fields of infectious diseases, oncology, and autoimmune disorders. What sets them apart is their commitment to innovation and quality, ensuring that their products meet stringent international standards. With a strong market presence, Kehua Bio has achieved notable milestones, including numerous certifications and partnerships that underscore its reputation as a trusted provider in the healthcare sector.
-19 vs industry average
Shanghai Kehua Bio-Engineering Co.,Ltd’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Shanghai Kehua Bio-Engineering Co.,Ltd yet.
Shanghai Kehua Bio-Engineering Co., Ltd, headquartered in China, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time.
As there are no emissions data or reduction initiatives available, it is important to note that the company may still be operating within an industry context that increasingly prioritises sustainability and climate action. Many organisations in the biotechnology sector are adopting measures to address climate change, and it is anticipated that Shanghai Kehua Bio-Engineering Co., Ltd may align with these trends in the future.
Overall, while specific emissions data and climate commitments are currently unavailable, the company’s future actions in this area will be crucial for its environmental impact and reputation in the industry.
No climate goals have been disclosed for Shanghai Kehua Bio-Engineering Co.,Ltd yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more